| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 06/21/2000 | CN1257489A Substituted benzopyran derivatives for the treatment of inflammation |
| 06/21/2000 | CN1257483A Substituted isoquinolines as ultra short acting neuromuscular blockers |
| 06/21/2000 | CN1257467A Reduction of aromatic halogenides |
| 06/21/2000 | CN1053671C Photochemistry gene recognition material and its preparation process and use |
| 06/21/2000 | CN1053666C Benzoheterocylic compounds and process for preparing medicated salt thereof |
| 06/21/2000 | CN1053662C New tricyclic amide compounds, processes for their preparation and the pharmaceutical compositions containing same |
| 06/20/2000 | US6077850 Useful for treating cyclooxygenase-2 mediated disorders, such as inflammation and inflammation-related disorders |
| 06/20/2000 | US6077844 Pyrimidine derivatives and methods of making and using these derivatives |
| 06/20/2000 | CA1341034C Heterocyclic 2-alkoxyphenoxysulfonylureas and the use thereof as herbicides or plant growth regulators |
| 06/15/2000 | WO2000034285A2 Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers |
| 06/15/2000 | WO2000034265A2 Quinoline-indole antimicrobial agents |
| 06/15/2000 | WO2000034262A1 Benzofuran derivatives, process for the preparation of the same and uses thereof |
| 06/15/2000 | WO2000033839A1 Non-peptide antagonists of glp-1 receptor and methods of use |
| 06/15/2000 | WO2000033833A1 Palladium-substituted bacteriochlorophyll derivatives and use thereof |
| 06/15/2000 | WO2000006531A3 Nitric esters and nitrate salts of specific drugs |
| 06/15/2000 | CA2350887A1 Non-peptide antagonists of glp-1 receptor and methods of use |
| 06/15/2000 | CA2350590A1 Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers |
| 06/14/2000 | EP1008589A1 Fungicidal imidazolinones |
| 06/14/2000 | EP1007533A1 Bioconjugates and delivery of bioactive agents |
| 06/14/2000 | EP1007527A1 Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same |
| 06/14/2000 | EP1007520A1 2-aminopyridines containing fused ring substituents as nos inhibitors |
| 06/14/2000 | EP1007056A1 Method for the treatment of cystic fibrosis |
| 06/14/2000 | EP1007033A1 Lymphocyte function antigen-1 antagonists |
| 06/13/2000 | US6075035 Crystal of hydrate and process for preparation thereof |
| 06/13/2000 | US6075018 Tranquilizers |
| 06/13/2000 | CA2085878C Bis-benzo or benzopyrido cyclo hepta piperidene, piperidylidene and piperazine compounds and compositions |
| 06/08/2000 | WO2000032649A1 Method of producing derivatized polymers |
| 06/08/2000 | WO2000032552A1 Process for the preparation of functionalized chiral cyclopentanes involving transformation of azanorbornyl derivatives |
| 06/08/2000 | WO2000023446A8 Core-extended perylene bisimides and the use thereof as fluorescent dyes |
| 06/07/2000 | EP1006116A1 Polymethine compounds, method of producing same, and use thereof |
| 06/07/2000 | EP1005464A1 Photochromic naphthopyrans |
| 06/07/2000 | EP0727994B1 Antipyretic and analgesic methods and compositions containing optically pure r-etodolac |
| 06/07/2000 | CN1255923A 6-substituted 1,2,4a,51,8a,8b hexahydro- and 1,2,3,4,4a,5a,8a,8b-octahydro-6h-pyrrolo [3',4': 4,5] furo [3,2-b] pyrid-8(7h)-on derivatives and their use in combatting encoparasites |
| 06/07/2000 | CN1255922A Phthalocyanine and use of phthalocyanine as marking agent |
| 06/07/2000 | CN1053188C Quinolizinone type compounds |
| 06/06/2000 | US6071948 Treatment of diseases caused by excessive blood vessel growth |
| 06/06/2000 | US6071946 Tricyclic urea compounds |
| 06/06/2000 | US6071929 Selective blockers of n-methyl-d-aspartic acid for teatment of nervous system and brain disorders or injuries |
| 06/06/2000 | US6071928 Spiro-piperidine derivatives and their use as therapeutic agents |
| 06/06/2000 | US6071927 Tachykinnin antagonists for the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia |
| 06/06/2000 | US6071895 Polar-substituted hydrocarbons |
| 06/02/2000 | WO2000031080A1 [pyrrole]naphthopyranes, their preparation, compositions and (co)polymer matrices containing them |
| 06/02/2000 | WO2000031040A1 Process for preparing bis n-substituted perylenetetra carboximides via bis (hydroxymethyl) perylenetetra carboximide |
| 06/02/2000 | WO2000031037A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 06/02/2000 | CA2351865A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 05/31/2000 | EP1004584A2 Pyranoquinoline derivatives as inhibitors of cell proliferation |
| 05/31/2000 | EP1004140A1 A well to substrate photodiode for use in a cmos sensor on a salicide process |
| 05/31/2000 | EP1003751A1 Hydroxamic acid substituted fused heterocyclic metalloproteinase inhibitors |
| 05/31/2000 | EP1003750A1 Methods of preparing and purifying 9-nitro-20-camptothecin |
| 05/31/2000 | EP1003749A1 8-SUBSTITUTED-9H-1,3-DIOXOLO/4,5-h/2,3/BENZODIAZEPINE DERIVATES, AS AMPA/KAINATERECEPTOR INHIBITORS |
| 05/31/2000 | EP1003740A2 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagoists |
| 05/31/2000 | EP1003726A1 Nitrophenyl-sulfonyl-imidazoles and use thereof for controlling vegetable and animal pests |
| 05/31/2000 | EP1003724A1 Substituted quinoline derivatives with antiviral action |
| 05/31/2000 | EP1003516A1 Methods of administering camptothecin compounds for the treatment of cancer with reduced side effects |
| 05/31/2000 | EP1003512A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
| 05/31/2000 | EP1003511A1 ALPHA 1aADRENERGIC RECEPTOR ANTAGONISTS |
| 05/31/2000 | CN1052979C Carbazolone derivatives and process for preparing same |
| 05/30/2000 | US6069148 Cycloalkano-pyridines |
| 05/30/2000 | CA1341007C Alkyl- and alkenylsulfonylureas which are substituted in the heterocycle, processes for their preparation, and their use as herbicides or plant growth regulators |
| 05/25/2000 | WO2000029406A2 Novel isoxazoline fibrinogen receptor antagonists |
| 05/25/2000 | WO2000029380A1 Tetrahydroisoquinoline derivatives as lhrh antagonists |
| 05/25/2000 | CA2351187A1 Tetrahydroisoquinoline derivatives as lhrh antagonists |
| 05/25/2000 | CA2345210A1 Novel isoxazoline fibrinogen receptor antagonists |
| 05/24/2000 | EP1002799A1 Optically pure androgen mediator |
| 05/24/2000 | EP1001970A1 Dipeptide derivatives as growth hormone secretagogues |
| 05/24/2000 | EP1001940A1 Condensed pyrazole compounds |
| 05/24/2000 | EP1001766A1 Compounds and methods |
| 05/24/2000 | EP1001761A1 Use of cholinesterase inhibitors for treating attention deficit disorders |
| 05/24/2000 | EP0931083A4 Process for producing ecteinascidin compounds |
| 05/24/2000 | CN1254337A N-hydroxy 4-sulfonyl butyramide compounds |
| 05/24/2000 | CN1052726C 7-azabicyclo-[2,2,1]-heptane and-heptene derivatives as analgesics and anti-inflammatory agents |
| 05/24/2000 | CN1052722C Dibenzooxapine or thiapine derivative, its preparing method and drug composition |
| 05/23/2000 | US6066741 Process for the preparation of etodolac |
| 05/23/2000 | US6066644 Treatment of various cns disorders |
| 05/23/2000 | US6066635 Anticarcinogenic agents |
| 05/18/2000 | WO2000027830A1 Thiocarbamic acid derivatives |
| 05/18/2000 | WO2000027822A2 Tricyclic pyrazole derivatives |
| 05/18/2000 | WO2000004892A3 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 05/18/2000 | CA2350235A1 Tricyclic pyrazole derivatives |
| 05/17/2000 | EP1000035A1 Substituted 6-phenylphenanthridines |
| 05/17/2000 | EP1000034A1 Substituted 6-alkylphenanthridines |
| 05/17/2000 | CN1253559A Sulfonyl divalent aryl alpha-hydroxamic acid compounds |
| 05/17/2000 | CN1253547A 1,4-substituted cyclic amine derivatives |
| 05/17/2000 | CN1253474A Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/16/2000 | US6063923 Cyclization of 4-ethyl-4-hydroxy-7-(7-iodo-9-(4-methyl piperazin-1-ylmethyl)-2,3-dihydro-(1,4)dioxino(2,3-g)quinolin -8-ylmethyl)-4,7-dihydro-1h-pyrano(3,4-c)pyridine-3,8-dione, resolving mixture to yield desired enantiomer |
| 05/16/2000 | US6063847 Thrombin receptor antagonists |
| 05/16/2000 | US6063804 Pyrrole compounds |
| 05/16/2000 | US6063801 Heterocyclic topoisomerase poisons |
| 05/11/2000 | WO2000026203A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/11/2000 | WO2000013015A8 Modulating multiple lineage kinase proteins |
| 05/11/2000 | CA2347060A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/10/2000 | EP0999239A2 Heterocyclic compounds |
| 05/10/2000 | EP0999212A1 Furopyridine antibacterials |
| 05/10/2000 | EP0998674A2 Conjugate for differentiating between healthy and unhealthy tissue |
| 05/10/2000 | EP0998460A1 Novel tetrazole derivatives |
| 05/10/2000 | EP0998285A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
| 05/10/2000 | CN1052231C 2-oxo-5-oxazolidone methyl compound their preparing method and medicinal composition containing them |
| 05/09/2000 | US6060600 Substituted tetronic acids useful for treating HIV and other retroviruses |
| 05/09/2000 | US6060469 Spiro-piperidine derivatives and their use as tachykinin antagonists |
| 05/09/2000 | US6060468 N-substituted azaheterocyclic compounds |